EnteroBiotix CEO featured on The Pharma Letter podcast talking about mastering the microbiome

Our Founder & CEO Dr James McIlroy was recently featured on The Pharma Letter podcast with Simon Wentworth discussing mastering the microbiome.

James discusses how EnteroBiotix is developing its pipeline of highly diverse microbiome enhancing therapeutics through a unique approach to development and manufacturing, focussed on supply chain control and novel technologies.

Listen here to learn more about the future of modern medicine and the massive therapeutic potential of the gut microbiome.